25% of UK physicians "treat on-line drug adverse events"

16 April 2009

A survey by GP Magazine, a UK publication for general practitioners, has found that 25% of 423 respondents had treated patients for adverse  reactions caused by a drug purchased over the Internet. The figure could  be higher, as 8% said they were unsure.

Although a high proportion of physicians surveyed favored tighter  controls against on-line pharmacies, no specific ideas were presented as  to how this might be accomplished. The Royal Pharmaceutical Society of  Great Britain, which represents pharmacists, has launched a scheme to  ensure that approved web sites carry a logo from the Society.

Bill Beeby, the lead member on prescribing for the British Medical  Association's General Practioner Committee, told GP Magazine: "when it  comes to buying drugs on the Internet, it is a minefield. People just do  not know what they will be receiving. I would not advise any of my  patients to go down that route." He claimed that the extent of the  problem of counterfeit, substandard or inappropriate medicines being  obtained by UK patients is unknown.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight